Outcomes of Daratumumab, Pomalidomide, and Dexamethasone (DPd) Followed by High-Dose Chemotherapy and Autologous Stem Cell Transplantation (HDCT/ASCT) in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)

被引：0
|
作者：
Abdallah, Al-Ola [1 ]
Mohyuddin, Ghulam Rehman [1 ]
Mahmoudjafari, Zahra [2 ]
Shebli, Atrash [3 ]
Kawsar, Hameem [2 ]
Sigle, Monia [2 ]
Shune, Leyla [1 ]
McGuirk, Joseph [1 ]
Ganguly, Siddhartha [1 ]
机构：
[1] Univ Kansas, Med Ctr, Div Hematol Malignancies & Cellular Therapeut, Westwood, KS USA
[2] Univ Kansas, Med Ctr, Westwood, KS USA
[3] Atrium Hlth, Levine Canc Inst, Charlotte, NC USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2020年 / 20卷
关键词：
daratumumab; pomalidomide; relapsed/refractory myeloma; MM;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MM-235
引用
收藏
页码：S303 / S303
页数：1
相关论文
共 50 条
  • [21] Treatment outcomes in multiple sclerosis (MS) patients after high-dose chemotherapy (HDCT) with autologous stem cell transplantation (ASCT): Longterm follow-up.
    Slievchenko, Y. L.
    Novik, A. A.
    Afanasiev, B. V.
    Lisukov, I. A.
    Rykavicin, O. A.
    Shamanski, S. V.
    Ionova, T. I.
    Kulagin, A. D.
    Malysheva, O. A.
    Bisaga, G. N.
    Baziy, N. I.
    Melnichenko, V. Y.
    Fedorenko, D. A.
    Vereschagina, I. V.
    Kishtovich, A. V.
    Fedotov, Y. N.
    Gorodokin, N.
    Ivanov, R. A.
    CYTOTHERAPY, 2006, 8
  • [22] High-dose chemotherapy with autologous hematopoietic stem cell transplantation in patients with multiple myeloma
    Gertz, Marie A.
    Lacy, Martha Q.
    Dispenzieri, Angela
    Hayman, Suzanne R.
    Kumar, Shaji K.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2006, 6 (03) : 343 - 360
  • [23] High-dose chemotherapy followed by autologous stem cell transplantation changes prognosis of IgD multiple myeloma
    Maisnar, V.
    Hajek, R.
    Scudla, V.
    Gregora, E.
    Buchler, T.
    Tichy, M.
    Kotoucek, P.
    Kafkova, A.
    Forraiova, L.
    Minarik, J.
    Radocha, J.
    Blaha, V.
    Maly, J.
    BONE MARROW TRANSPLANTATION, 2008, 41 (01) : 51 - 54
  • [24] High-dose chemotherapy followed by autologous stem cell transplantation changes prognosis of IgD multiple myeloma
    V Maisnar
    R Hájek
    V Ščudla
    E Gregora
    T Büchler
    M Tichý
    P Kotouček
    A Kafková
    L Forraiová
    J Minařík
    J Radocha
    V Bláha
    J Malý
    Bone Marrow Transplantation, 2008, 41 : 51 - 54
  • [25] Immunomodulation in Pomalidomide, Dexamethasone, and Daratumumab-Treated Patients with Relapsed/Refractory Multiple Myeloma
    Pierceall, William E.
    Amatangelo, Michael D.
    Bahlis, Nizar J.
    Siegel, David S.
    Rahman, Adeeb
    Van Oekelen, Oliver
    Neri, Paola
    Young, Mary
    Chung, Weiyuan
    Serbina, Natalya
    Parekh, Samir
    Agarwal, Amit
    Thakurta, Anjan
    CLINICAL CANCER RESEARCH, 2020, 26 (22) : 5895 - 5902
  • [26] Relapsed and primary refractory Diffuse Large Cell Lymphoma (DLCL) salvaged with Involved Field Radiotherapy (IFRT) & High Dose Chemotherapy (HDCT) followed by Autologous Stem Cell Transplantation (ASCT)
    Hoppe, B. S.
    Moskowitz, C. H.
    Moskowitz, C. S.
    Filippa, D. A.
    Kewalramani, T.
    Yahalom, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S537 - S537
  • [27] Autologous stem cell transplantation (ASCT) followed by consolidation chemotherapy for multiple myeloma (MM).
    Gojo, I
    Murthy, A
    Fassas, A
    Tricot, G
    Fenton, R
    Mookerjee, B
    Meisenberg, B
    Takebe, N
    Frankel, SR
    Sarkodee-Adoo, C
    Heyman, MR
    Ruehle, K
    Smith, R
    Chen, T
    Rapoport, A
    BLOOD, 2000, 96 (11) : 369B - 369B
  • [28] Autologous stem cell transplantation (ASCT) followed by consolidation chemotherapy for multiple myeloma (MM).
    Murthy, A
    Gojo, I
    Fassas, A
    Tricot, G
    Fenton, R
    Mookerjee, B
    Meisenberg, B
    Takebe, N
    Lipani, T
    Badros, A
    Phillips, G
    Sarkodee-Adoo, C
    Heyman, M
    Ruehle, K
    Smith, R
    Guo, CF
    Rapoport, A
    BLOOD, 2001, 98 (11) : 685A - 685A
  • [29] Melflufen Therapy for Relapsed Refractory Multiple Myeloma (RRMM) Patients Refractory to Daratumumab and/or Pomalidomide: A Report on Early Efficacy
    Mateos, Maria-Victoria
    Blade, Joan
    Larocca, Alessandra
    Oriol, Albert
    Rodriguez, Paula
    Alegre, Adrian
    Cavo, Michele
    Moreb, Jan S.
    Paner, Agne
    Gabrail, Nashat
    Halka, Kathleen G.
    Hassoun, Hani
    Maisel, Christopher
    Mazumder, Amitabha
    Zonder, Jeffrey A.
    Ocio, Enrique M.
    Byrne, Catriona
    Harmenberg, Johan
    Thuresson, Sara
    Nordstrom, Eva
    Lindberg, Jakob
    Richardson, Paul G.
    BLOOD, 2017, 130
  • [30] Safety of Zevalin® plus high dose chemotherapy and autologous stem cell transplantation (ASCT) in patients with relapsed or refractory NHL
    Madar, Olivier
    Salmon, Maxime
    Mounier, Nicolas
    Madelaine-Chambrin, Isabelle
    Faure, Pierre
    PHARMACY WORLD & SCIENCE, 2007, 29 (05): : 505 - 506
12345